Workshops

​​​​​WORKSHOP TITLES BY TRACK

TRACK 1 – VASCULAR BIOLOGY OF THE ARTERY WALL

  • ​ STEM CELLS AND VASCULAR DISEASE
    • Embryonic stem cells in vascular disease research
      Sanjay Sinha, UK​
    • Progenitor cells and vascular remodeling
      Paulo Maddedu, UK​
  • ​EPIGENETICS AND NON-CODING RNA IN VASCULAR BIOLOGY
    • Micro RNAs and their role in atherosclerosis
      Christian Weber, Germany
    • Epigenetic programming of metabolism by diet
      Suzanne Ozanne, UK​
  • ​​MICROVESSELS AND ANGIO-GENESIS IN ATHEROSCLEROSIS
    • Angiogenesis and its role in vascular disease
      Seppo Ylä Hertualla, Finland
    • Controlling the entry of leukocytes
      Dietmar Vestweber, Germany​​
  • MITOCHONDRIAL DYSFUNCTION AND OXIDATIVE STRESS IN VASCULAR DISEASE​
    • Redox signaling in atherosclerosis/ vascular diseases
      Massimo Santoro, Italy​​
    • A new look at paraoxonase and its role in cardiovascular disease
      Jordi Camps J., Spain​

TRACK 2 – LIPID AND LIPOPROTEIN METABOLISM

  • ​NOVEL REGULATORY MECHA-NISMS IN LIPID TRANSPORT
    • Role of HDL receptors in lipid transport
      Laurent O. Martinez, France​
    • Insights into apoC-III and the regulation of lipid metabolism
      Zemin Yao, Canada​
  • ​GENETIC REGULATION OF LIPID METABOLISM
    • Regulation of cellular cholesterol homeostasis
      Noam Zelcer, The Netherlands​
    • Co-regulation of metabolism and inflammation
      Bart Staels, France
  • FH AND SEVERE HYPERLIPIDEMIAS​
    • Familial Hypercholesterolemia - the next 10 years
      Kees Hovingh, The Netherlands​
    • Understanding combined hyperlipidemia its aetiology and treatment
      Maurizio Averna, Italy​
  • NEW INSIGHTS INTO HDL FUNCTION
    • LCAT and HDL function
      Laura Calabresi, Italy
    • Determinants of HDL function and dysfunction
      Ulf Landmesser, Switzerland​
​TRACK 3 – RISK FACTORS, PREVENTION AND TREATMENT OF CVD
  • ​GENES AS RISK FACTORS FOR CVD
    • Genetic regulation of cholesterol transport and risk of cardiovascular disease, diabetes, and dementia
      Ruth Frikke-Schmidt, Denmark
    • Genetic regulation of plasma triglyceride
      Rob Hegele, Canada​
  • CVD PREDICTION AND NOVEL BIOMARKERS 
    • Novel biomarkers of lipid and lipoprotein metabolism
      ​Samia Mora, USA
    • Risk Factors and Biomarkers beyond Lipids and Lipoproteins
      Olle Melander, Sweden
  • ​MICRONUTRIENTS AND VITAMINS IN POPULATION CVD HEALTH
    • Micronutrients and their impact on cardiovascular disease
      Ian S. Young, UK​
    • Vitamin D risk factor and therapeutic target?
      Sabine Rohrmann, Switzerland
  • LP(a) AND NOVEL LIPID TARGETS
    • Insights into Lipoprotein(a) and its role as a risk factor and treatment target
      Florian Kronenberg, Austria
    • Atypical sphingolipids in atherosclerosis
      Thorsten Hornemann, Switzerland​

TRACK 4 – ADVANCED CLINICAL SEMINARS

  • ​NOVEL STRATEGIES IN LIPID LOWERING AND ANTI-ATHERO-SCLEROSIS ​INTERVENTIONS
    • The Modulation of Cardiovascular Risk Factors with Second Generation Antisense Oligonucleotides
      Sotirios ​Tsimikas, USA
    • Targeting non-coding RNA and genes in vascular remodeling
      Andy Baker, UK
  • ​IMAGING ATHEROSCLEROSIS- DIAGNOSTIC AND PROGNOSTIC USES
    • New approaches to assessing vascular disease with ultrasound technology
      Michiel L. Bots, The Netherlands
    • Advances in imaging atherosclerosis
      Colin Berry, UK
  • ​THERAPEUTIC CHALLENGES IN STATIN INTOLERANCE AND SECONDARY DYSLIPIDEMIA
    • The reality and challenge of statin intolerance
      Olov Wiklund, Sweden
    • How safe are statins?
      Colin Baigent, UK
  • ​NEW METRICS AND MODELLING FOR CVD RISK PREDICTION

 

Keep Me Updated